Defining the role of left atrial appendage closure in atrial fibrillation;Definición del papel de la oclusión de la orejuela auricular izquierda en la fibrilación auricular

Revista Espanola de Cardiologia

Volumn 66, Issue 2, 2013, Pages 79-82

  Andreotti, Felicita ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEART ATRIUM FIBRILLATION; HEART SURGERY; REVIEW; ATRIAL FIBRILLATION; FEMALE; HEART ATRIUM APPENDAGE; HUMAN; MALE; SEPTAL OCCLUDER;

ATRIAL APPENDAGE; ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE; SEPTAL OCCLUDER DEVICE;

EID: 84938680790     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2012.09.013     Document Type: Article

References (15)

1. U. Landmesser, and D.R. Holmes Jr. Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation Eur Heart J 33 2012 698 704
2. A.J. Camm, G.Y. Lip, R. De Caterina, I. Savelieva, D. Atar, S.H. Hohnloser ESC Committee for Practice Guidelines (CPG) 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation developed with the special contribution of the European Heart Rhythm Association Eur Heart J 33 2012 2719 2747 10.1093/eurheartj/ehs253
3. J.R. López-Mínguez, J. Eldoayen-Gragera, R. González-Fernández, C. Fernández-Vegas, M.E. Fuentes-Cañamero, and V. Millán-Nuñez Resultados inmediatos y a más de un año en 35 pacientes consecutivos a los que se realiza cierre de orejuela izquierda con el dispositivo Amplatzer Cardiac Plug Rev Esp Cardiol 66 2013 90 97
4. M. Zabalgoitia, J.L. Halperin, L.A. Pearce, J.L. Blackshear, R.W. Asinger, R.G. Hart Stroke Prevention in Atrial Fibrillation III Investigators Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation J Am Coll Cardiol 31 1998 1622 1626
5. R. Mahajan, A.G. Brooks, T. Sullivan, H.S. Lim, M. Alasady, and H.S. Abed Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure Heart 98 2012 1120 1126
6. E.E. Guérios, M. Schmid, S. Gloekler, A.A. Khattab, P.M. Wenaweser, and S. Windecker Left atrial appendage closure with the Amplatzer Cardiac Plug in patients with atrial fibrillation Arq Bras Cardiol 98 2012 528 536
7. Y.L. Bayard, H. Omran, P. Neuzil, L. Thuesen, M. Pichler, and E. Rowland PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study EuroIntervention 6 2010 220 226
8. V.Y. Reddy, D. Holmes, S.K. Doshi, P. Neuzil, and S. Kar Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the continued access registry Circulation 123 2011 417 424
9. D.R. Holmes, V.Y. Reddy, Z.G. Turi, S.K. Doshi, H. Sievert, M. Buchbinder PROTECT AF Investigators Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomized, non-inferiority trial Lancet 374 2009 534 542
10. Without warfarin, Watchman still prevents strokes, says registry [citado 15 Sep 2012]. Disponible en: www.theheart.org/article/1398695.do
11. J. Mant, F.D. Hobbs, K. Fletcher, A. Roalfe, D. Fitzmaurice, G.Y. Lip BAFTA investigators Midland Research Practices Network (MidReC). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 370 2007 493 503
12. ACTIVE Writing Group of the ACTIVE Investigators S. Connolly, J. Pogue, R. Hart, M. Pfeffer, S. Hohnloser, and S. Chrolavicius Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 2006 1903 1912
13. S.J. Connolly, J. Eikelboom, C. Joyner, H.C. Diener, R. Hart, S. Golitsyn AVERROES Steering Committee and Investigators Apixaban in patients with atrial fibrillation N Engl J Med 364 2011 806 817
14. R. De Caterina, S. Husted, L. Wallentin, F. Andreotti, H. Arnesen, and F. Bachmann New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC working group on thrombosis-task force on anticoagulants in heart disease position paper J Am Coll Cardiol 59 2012 1413 1425
15. F. Andreotti, and T. Pafundi Los nuevos anticoagulantes y el futuro de la cardiología Rev Esp Cardiol 63 2010 1223 1229